| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.18 | 7e-06 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-06 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.25 | 2e-05 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-05 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |